Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free THMO Stock Alerts

ThermoGenesis (THMO) Competitors

ThermoGenesis logo
Compare

THMO vs. TBIO, HTGMQ, OLITW, PRENW, and QSIAW

Should you buy ThermoGenesis stock or one of its competitors? MarketBeat compares ThermoGenesis with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with ThermoGenesis include Telesis Bio (TBIO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), and Quantum-Si (QSIAW). These companies are all part of the "measuring and control equipment" industry.

How does ThermoGenesis compare to Telesis Bio?

ThermoGenesis (NASDAQ:THMO) and Telesis Bio (NASDAQ:TBIO) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends.

ThermoGenesis has a beta of 1.13, suggesting that its share price is 13% more volatile than the broader market. Comparatively, Telesis Bio has a beta of 2.43, suggesting that its share price is 143% more volatile than the broader market.

ThermoGenesis has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%.

Company Net Margins Return on Equity Return on Assets
ThermoGenesisN/A N/A N/A
Telesis Bio -336.59%N/A -61.89%

ThermoGenesis has higher earnings, but lower revenue than Telesis Bio. Telesis Bio is trading at a lower price-to-earnings ratio than ThermoGenesis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A
Telesis Bio$225.09M0.00-$47.72M-$20.52N/A

In the previous week, ThermoGenesis' average media sentiment score of 0.00 equaled Telesis Bio'saverage media sentiment score.

Company Overall Sentiment
ThermoGenesis Neutral
Telesis Bio Neutral

5.8% of ThermoGenesis shares are held by institutional investors. Comparatively, 37.6% of Telesis Bio shares are held by institutional investors. 78.0% of ThermoGenesis shares are held by company insiders. Comparatively, 24.5% of Telesis Bio shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

ThermoGenesis beats Telesis Bio on 6 of the 9 factors compared between the two stocks.

How does ThermoGenesis compare to HTG Molecular Diagnostics?

HTG Molecular Diagnostics (NASDAQ:HTGMQ) and ThermoGenesis (NASDAQ:THMO) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, media sentiment, analyst recommendations, institutional ownership and profitability.

5.8% of ThermoGenesis shares are held by institutional investors. 2.6% of HTG Molecular Diagnostics shares are held by insiders. Comparatively, 78.0% of ThermoGenesis shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
HTG Molecular DiagnosticsN/A N/A N/A
ThermoGenesis N/A N/A N/A

In the previous week, HTG Molecular Diagnostics' average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score.

Company Overall Sentiment
HTG Molecular Diagnostics Neutral
ThermoGenesis Neutral

HTG Molecular Diagnostics has a beta of 3.06, meaning that its share price is 206% more volatile than the broader market. Comparatively, ThermoGenesis has a beta of 1.13, meaning that its share price is 13% more volatile than the broader market.

ThermoGenesis has higher revenue and earnings than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A

Summary

ThermoGenesis beats HTG Molecular Diagnostics on 5 of the 7 factors compared between the two stocks.

How does ThermoGenesis compare to OmniLit Acquisition?

ThermoGenesis (NASDAQ:THMO) and OmniLit Acquisition (NASDAQ:OLITW) are both measuring and control equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, dividends, profitability, risk and valuation.

Company Net Margins Return on Equity Return on Assets
ThermoGenesisN/A N/A N/A
OmniLit Acquisition N/A N/A N/A

5.8% of ThermoGenesis shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, ThermoGenesis' average media sentiment score of 0.00 equaled OmniLit Acquisition'saverage media sentiment score.

Company Overall Sentiment
ThermoGenesis Neutral
OmniLit Acquisition Neutral

OmniLit Acquisition has lower revenue, but higher earnings than ThermoGenesis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A
OmniLit AcquisitionN/AN/AN/AN/AN/A

Summary

ThermoGenesis beats OmniLit Acquisition on 3 of the 3 factors compared between the two stocks.

How does ThermoGenesis compare to Prenetics Global?

ThermoGenesis (NASDAQ:THMO) and Prenetics Global (NASDAQ:PRENW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, analyst recommendations, dividends, valuation and profitability.

In the previous week, ThermoGenesis' average media sentiment score of 0.00 equaled Prenetics Global'saverage media sentiment score.

Company Overall Sentiment
ThermoGenesis Neutral
Prenetics Global Neutral

5.8% of ThermoGenesis shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
ThermoGenesisN/A N/A N/A
Prenetics Global N/A N/A N/A

Prenetics Global has higher revenue and earnings than ThermoGenesis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A
Prenetics Global$120.07MN/AN/AN/AN/A

Summary

ThermoGenesis beats Prenetics Global on 2 of the 3 factors compared between the two stocks.

How does ThermoGenesis compare to Quantum-Si?

Quantum-Si (NASDAQ:QSIAW) and ThermoGenesis (NASDAQ:THMO) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, media sentiment, valuation, analyst recommendations, risk and institutional ownership.

5.8% of ThermoGenesis shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Quantum-Si has higher earnings, but lower revenue than ThermoGenesis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Quantum-Si$1.85MN/AN/AN/AN/A
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A

Company Net Margins Return on Equity Return on Assets
Quantum-SiN/A N/A N/A
ThermoGenesis N/A N/A N/A

In the previous week, Quantum-Si's average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score.

Company Overall Sentiment
Quantum-Si Neutral
ThermoGenesis Neutral

Summary

ThermoGenesis beats Quantum-Si on 3 of the 3 factors compared between the two stocks.

Get ThermoGenesis News Delivered to You Automatically

Sign up to receive the latest news and ratings for THMO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding THMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

THMO vs. The Competition

Export
MetricThermoGenesisLaboratory apparatus & furniture IndustryMedical SectorNASDAQ Exchange
Market Cap$1K$1K$7.17B$12.48B
Dividend YieldN/AN/A2.66%6.52%
P/E Ratio0.00N/A27.7524.69
Price / SalesN/A0.00535.1798.72
Price / CashN/AN/A29.6549.23
Price / BookN/AN/A10.976.49
Net Income-$17.98M-$17.98M$3.57B$336.25M

ThermoGenesis Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
THMO
ThermoGenesis
N/AN/AN/AN/A$1K$9.61MN/A40
TBIO
Telesis Bio
N/A$0.00
flat		N/AN/A$2K$225.09MN/A200
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/A$0.00$6.37MN/A90
OLITW
OmniLit Acquisition
N/A$1.67
flat		N/A+2,285.7%$0.00N/AN/A3
PRENW
Prenetics Global
N/A$0.01
flat		N/A-64.5%$0.00$120.07MN/A1

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:THMO) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
From the man who predicted 2008 crash…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel